Abstract
Cardiac hemochromatosis can cause heart failure and cardiac arrhythmias. Among these arrhythmias, ventricular tachycardia may be resistant to treatment. A case of cardiac hemochromatosis complicated with ventricular tachycardia that did not respond to intravenous lidocaine, procainamide or propafenone, nor to DC cardioversion, was successfully treated with amiodarone. Amiodarone, a class III antiarrhythmic drug, may be highly effective in similar cases.
MeSH terms
-
Adolescent
-
Amiodarone / therapeutic use*
-
Anti-Arrhythmia Agents / therapeutic use*
-
Biopsy
-
Cardiomyopathies / complications*
-
Cardiomyopathies / diagnosis
-
Cardiomyopathies / physiopathology
-
Electrocardiography
-
Hemochromatosis / complications*
-
Hemochromatosis / diagnosis
-
Hemochromatosis / physiopathology
-
Humans
-
Male
-
Tachycardia, Ventricular / drug therapy*
-
Tachycardia, Ventricular / etiology
-
Tachycardia, Ventricular / physiopathology
Substances
-
Anti-Arrhythmia Agents
-
Amiodarone